Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin: A randomized controlled trial

Archives of Internal Medicine

Volumn 157, Issue 14, 1997, Pages 1537-1544

  Piazza, Marcello ^a   Sagliocca, Luciano ^b   Tosone, Grazia ^a   Guadagnino, Vincenzo ^c   Stazi, Maria Antonietta ^d   Orlando, Raffaale ^a   Borgia, Guglielmo ^a   Rosa, Domenico ^e   Abrignani, Sergio ^e   Palumbo, Filippo ^f   Manzin, Aldo ^g   Clementi, Massimo ^h  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Servizio Epidemiologia e Prevenzione   (Italy)

^c UNIVERSITY MEDITERRANEA OF REGGIO CALABRIA   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e CHIRON VACCINES   (Italy)

^f Osserv Epidemiologico Regione C   (Italy)

^g UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^h UNIVERSITY OF TRIESTE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; GLOBUMAN BERNA; IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; INTRAMUSCULAR DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROPHYLAXIS; RANDOMIZED CONTROLLED TRIAL; SEQUENCE ANALYSIS; SEQUENCE HOMOLOGY; SEXUAL TRANSMISSION; SINGLE BLIND PROCEDURE;

EID: 0030835372     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.157.14.1537     Document Type: Article

References (66)

1. Alter MJ. The detection, transmission, and outcome of hepatitis C virus. Infect Agents Dis. 1993;2:155-166.
2. Everhart JE, DiBisceglie AM, Murray LM, et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med. 1990;112:544-546.
3. Tor J, Llibre JM, Carbonell M, et al. Sexual transmission of hepatitis C virus and its relation with hepatitis B virus and HIV. BMJ. 1990;301:1130-1133.
4. Peano GM, Fenoglio LM, Menardi G, Balbo R. Marenchino D, Fenoglio S. Heterosexual transmission of hepatitis C virus in family groups without risk factors. BMJ. 1992;305:1473-1474.
5. Akahane Y, Aikawa T, Sugai Y, Tsuda F. Okamoto H, Mishiro S. Transmission of HCV between spouses. Lancet. 1992;339:1059-1060.
6. Kao J-H, Chen P-J, Yang P-M, et al. Intrafamilial transmission of hepatitis C virus: the important role of infection between spouses. J Infect Dis. 1992;166: 900-903.
7. Rice PS, Smith DB, Simmonds P, Holmes E. Heterosexual transmission of hepatitis C virus. Lancet. 1993;342:1052-1053.
8. Honda M, Kaneko S, Unoura M, Kobayashi K, Murakami S. Risk of hepatitis C virus infections through household contact with chronic carriers: analysis of nucleotide sequences. Hepatology. 1993;17:971-976.
9. Osmond DH, Padian NS, Sheppard HW, Glass S, Shiboski SC, Reingold A. Risk factors for hepatitis C virus seropositivity in heterosexual couples. JAMA. 1993; 269:361-365.
10. Bresters D, Mauser-Bunschoten EP, Reesink HW, et al. Sexual transmission of hepatitis C virus. Lancet. 1993;342:210-211.
11. Hallam NF, Fletcher ML, Read SJ, Majid AM, Kurtz JB, Rizza CR. Low risk of sexual transmission of hepatitis C virus. J Med Virol. 1993;40:251-253.
12. Chang T-T, Liou T-C, Young K-C, et al. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol. 1994;42:91-96.
13. Thomas DL, Cannon RO, Shapiro CN, Hook EW III, Alter MJ, QuinnTC. Hepatitis C, hepatitis B, and human immunodeficiency virus infections among non-intravenous drug-using patients attending clinics for sexually transmitted diseases. J Infect Dis. 1994;169:990-995.
14. Akahane Y, Kojima M, Sugai Y, et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med. 1994;120:748-752.
15. McGovern TW, Holtzmuller KC, Sherman KE, et al. Hepatitis C virus infections in US families. In: Nishioka K, Suzuki H, Mishiro S, OdaT, eds. Viral Hepatitis and Liver Disease. Tokyo, Japan: Springer-Verlag; 1994:450-454.
16. Ohmo T, Mizokami M, Lau JYN, et al. Sexual transmission of hepatitis C virus. In: Nishioka K, Suzuki H, Mishiro S, Oda T, eds. Viral Hepatitis and Liver Disease. Tokyo, Japan: Springer-Verlag; 1994:455-458.
17. Setoguchi Y, Kajihara S, Hara T, et al. Analysis of nucleotide sequences of hepatitis C virus isolates from husband-wife pairs. J Gastroenterol Hepatol. 1994;9: 468-471.
18. Chayama K, Kobayashi M, Tsubota A, et al. Molecular analysis of intraspousal transmission of hepatitis C virus. J Hepatol. 1995;22:431 -439.
19. Kao J-H, Hwang Y-T, Chen P-J, et al. Transmission of hepatitis C virus between spouses: the important role of exposure duration. Am J Gastroenterol. 1996;91: 2087-2090.
20. Schiff ER. Hepatitis C among health care providers: riskfactors and possible prophylaxis. Hepatology. 1992;16:1300-1301.
21. Gerberding JL, Henderson DK. Management of occupational exposures to bloodborne pathogens: hepatitis B virus, hepatitis C virus, and human immunodeficiency virus. Clin Infect Dis. 1992;14:1179-1185.
22. PHLS Hepatitis Subcommittee. Hepatitis C virus: guidance on the risks and current management of occupational exposure. Commun Dis Rep CDR Rev. 1993; 3:R135-R139.
23. Centers for Disease Control. Public Health Service inter-agency guidelines for screening donors of blood, plasma, organs, tissues, and semen for evidence of hepatitis B and hepatitis C. MMWR Morb Mortal Wkly Rep. 1991;40:1 -17.
24. Seeff LB, Zimmerman HJ, Wright EC, et al. A randomized, double-blind, controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. Gastroenterology. 1977;72:111-121.
25. Seeff LB, Hoofnagle JH. Immunoprophylaxis of viral hepatitis. Gastroenterology 1979;77:161-182.
26. Knodell RG, Conrad ME, Ginsberg AL, Bell CJ. Efficacy of prophylactic gammaglobulin in preventing non-A, non-B post-transfusion hepatitis. Lancet. 1976;1: 557-561.
27. Knodell RG, Conrad ME, Ishak KG. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis: role of γ-globulin prophylaxis in its prevention. Gastroenterology. 1977;72:902-909.
28. Sanchez-Quijano A, Pineda JA, Lissen E, et al. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunglobulin in heart surgery patients. Lancet. 1988;1:1245-1249.
29. Conrad ME, Lemon SM. Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin. J Infect Dis. 1987;156:56-63.
30. Piazza M. Periodic gammaglobulin to prevent hepatitis C in at-risk sexual partners. Lancet. 1990;336:823-824.
31. Lentner C, ed. Geigy Scientific Tables. 8th ed. Basel, Switzerland: Ciba-Geigy Ltd; 1982:2.
32. Fleiss JL. Statistical Methods for Rates and Proportions. 2nd ed. New York, NY: John Wiley & Sons Inc; 1981.
33. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidiumthiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156-159.
34. Garson JA, Tedder RS, Briggs M, et al. Detection of hepatitis viral sequences in blood donations by 'nested' polymerase chain reaction and prediction of infectivity. Lancet. 1990;335.1419-1422.
35. Okamoto H, Tokita H, Sakamoto M, et al. Characterization of the genomic sequence of type V (or 3a) hepatitis C virus isolates and PCR primers for specific detection. J Gen Virol. 1993;74:2385-2390.
36. Silini E, Bono F, Cividini A, et al. Differential distribution of hepatitis C virus genotypes in patients with and without liver function abnormalities. Hepatology. 1995; 21:285-290.
37. Simmonds P, Alberti A, Alter HJ, et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994;19:1321-1324.
38. Okamoto H, Kurai K, Okada S, et al. Full-length sequence of a hepatitis C virus genome having poor homology to reported isolates: comparative study of four distinct genotypes. Virology. 1992;188:331-341.
39. Chien DY, Choo Q-L, Ralston R, et al. Persistence of HCV despite antibodies to both putative envelope glycoproteins. Lancet. 1993;342:933.
40. Rosa D, Campagnoli S, Moretto C, et al. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: cytofluorimetnc assessment of envelope glycoprotein E2 binding to target cells. Proc Natl Acad Sci U S A. 1996;93: 1759-1763.
41. Cox DR. Regression model and life tables. J R Stat Soc. 1972;34:187-220.
42. Sackett DL, Cook RJ. Understanding clinical trials: what measures of efficacy should a journal article provide a busy clinician? BMJ. 1994;309:755-756.
43. Piazza M, Chien D, Quan S, Houghton M. Lack of antibodies to the envelope glycoproteins of hepatitis C virus in immunoglobulin preparations from screened donors. J Biol Res - Boll Soc Ital Biol Sper. 1996;72:69-70.
44. Martell M, Esteban JI, Quer J, et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution. J Virol. 1992;66:3225-3229.
45. Bukh J, Miller RH, Purcell RH. Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes. Semin Liver Dis. 1995;1:41-63.
46. Hagiwara H, Hayashi N, Mita E, et al. Quantitation of hepatitis C virus RNA in serum of asymptomatic blood donors and patients with type C chronic liver disease. Hepatology. 1993;17:545-550.
47. Piazza M, DiStasio G, Maio G, Marzano LA. Hepatitis B antigen inhibitor in human faeces and intestinal mucosa. BMJ. 1973;2:334-337.
48. Piazza M, Cacciatore L. Molinari V, Picciotto L. Hepatitis B not transmissible via fecal-oral route. Lancet. 1975;2:706-707.
49. Hepatitis B Transmission Modes: Evidence Against Enteric Transmission. Atlanta, Ga: Centers for Disease Control: 1977. US Dept of Health, Education, and Welfare publication 41.
50. Piazza M, Chirianni A, Picciotto L, Guadagnino V, Orlando R, Tullio Cataldo P. Passionate kissing and microlesions of oral mucosa: possible role in AIDS transmission. JAMA. 1989;261:244-245.
51. Liou T-C, Chang T-T, Young K-C, Lin X-Z, Wu H-L. Detection of HCV RNA in saliva, urine, seminal fluid, and ascites. J Med Virol. 1992;37:197-202.
52. Numata N, Ohori H, Hayakawa Y, Saitoh Y, Tsunoda A, Kanno A. Demonstration of hepatitis C virus genome in saliva and urine of patients with type C hepatitis: usefulness of the single round polymerase chain reaction method for detection of the HCV genome. J Med Virol. 1993;41:120-124.
53. Piazza M, Borgia G, Picciotto L, Nappa S, Cicciarello S, Orlando R. Detection of hepatitis C vinis-RNA by polymerase chain reaction in dental surgeries. J Med Virol. 1995;5:40-42.
54. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344:1475-1479.
55. Jarvis LM, Watson HG, McOmish F, Peutherer JF, Ludlam CA, Simmonds P. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused hemophiliacs. J Infect Dis. 1994;170:1018-1022.
56. Lai ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalassemic children. Lancet. 1994;343:388-390.
57. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science. 1992;258:135-140.
58. Choo Q-L, Kuo G, Ralston R, et al. Vaccination of chimpanzees against infection by the hepatitis C virus. Proc Natl Acad Sci U S A. 1994;91:1294-1298.
59. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci U S A. 1994;91:7792-7796.
60. Farci P, Shimoda A, Wong D, et al. Prevention of HCV infection in chimpanzees by hyperimmune serum against the hypervariable region (HVR1): emergence of neutralization escape mutants in vivo. Hepatology. 1995;22:220.
61. Shimizu YK, Hijikata M, Iwamoto A, Alter HJ, Purcell RH. Yoshikura H. Neutralizing antibodies against hepatitis C virus and the emergence of neutralization escape mutant viruses. J Virol. 1994;68:1494-1500.
62. Krawczynski K, Alter MJ, Tankersley DL, et al. Effect of immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis. 1996;173: 822-828.
63. Public health control of hepatitis A: memorandum from a WHO meeting. Bull World Health Organ. 1995;73:15-20.
64. Centers for Disease Control and Prevention. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 1996;45:1-30.
65. Samuel D, Muller R, Alexander G, et al. Liver transplantation in European patients with the hepatitis B surface antigen. N Eng J Med. 1993;329:1842-1847.
66. Gungor T, Funk M, Linde R, et al. Combined therapy in human immunodeficiency virus-infected children: a 4-year experience. Eur J Pediatr. 1993;152: 650-654.